CAD ACS & AMI
Part I: New Concepts in Acute Coronary Syndromes and Atrial Fibrillation.
Part II: New Concepts in Heart Failure and Diabetes.
This event is an accredited Group Learning Activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was developed by the Canadian VIGOUR Centre and was planned to achieve scientific integrity, objectivity and balance. This program was made possible through educational grants from AstraZeneca Canada Inc., Bayer Inc., BMS/Pfizer Alliance, Boehringer-Ingelheim Eli Lilly Alliance, Novartis Pharmaceuticals Canada Inc., and Sanofi Canada.
Click here to view the program!